Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies
SOLO I and SOLO II Investigators
Research output: Contribution to journal › Article › peer-review
19Scopus
citations
Fingerprint
Dive into the research topics of 'Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies'. Together they form a unique fingerprint.